Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2020 | |
| Sales | 47 |
| Cost of Goods | 13 |
| Gross Profit | 34 |
| Operating Expenses | 2,646 |
| Operating Income | -2,611 |
| Interest Expense | 672 |
| Other Income | -375 |
| Pre-tax Income | -3,658 |
| Income Tax | 12 |
| Net Income Continuous | -3,670 |
| Net Income | $-3,670 |
| EPS Basic Total Ops | -0.04 |
| EPS Diluted Total Ops | -0.04 |
| EBITDA(a) | $-2,589 |